全文获取类型
收费全文 | 17929篇 |
免费 | 1515篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 687篇 |
妇产科学 | 522篇 |
基础医学 | 2303篇 |
口腔科学 | 229篇 |
临床医学 | 2028篇 |
内科学 | 3377篇 |
皮肤病学 | 305篇 |
神经病学 | 1969篇 |
特种医学 | 298篇 |
外国民族医学 | 5篇 |
外科学 | 1942篇 |
综合类 | 142篇 |
一般理论 | 67篇 |
预防医学 | 2699篇 |
眼科学 | 262篇 |
药学 | 1142篇 |
1篇 | |
中国医学 | 38篇 |
肿瘤学 | 1337篇 |
出版年
2024年 | 35篇 |
2023年 | 253篇 |
2022年 | 397篇 |
2021年 | 912篇 |
2020年 | 551篇 |
2019年 | 755篇 |
2018年 | 860篇 |
2017年 | 612篇 |
2016年 | 628篇 |
2015年 | 692篇 |
2014年 | 901篇 |
2013年 | 1149篇 |
2012年 | 1592篇 |
2011年 | 1610篇 |
2010年 | 824篇 |
2009年 | 664篇 |
2008年 | 1132篇 |
2007年 | 1194篇 |
2006年 | 960篇 |
2005年 | 894篇 |
2004年 | 808篇 |
2003年 | 722篇 |
2002年 | 534篇 |
2001年 | 70篇 |
2000年 | 54篇 |
1999年 | 58篇 |
1998年 | 110篇 |
1997年 | 75篇 |
1996年 | 37篇 |
1995年 | 48篇 |
1994年 | 40篇 |
1993年 | 39篇 |
1992年 | 28篇 |
1991年 | 17篇 |
1990年 | 15篇 |
1989年 | 20篇 |
1987年 | 9篇 |
1986年 | 14篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 6篇 |
1982年 | 10篇 |
1981年 | 14篇 |
1980年 | 13篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1961年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 718 毫秒
51.
52.
Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? 总被引:5,自引:0,他引:5
Ora Israel Maya Mor Luda Guralnik Nirit Hermoni Diana Gaitini Rachel Bar-Shalom Zohar Keidar Ron Epelbaum 《Journal of nuclear medicine》2004,45(12):2045-2051
Rising serum tumor markers may be associated with negative imaging in the presence of cancer. CT and (18)F-FDG PET may yield incongruent results in the assessment of tumor recurrence. The present study evaluates the incremental role of (18)F-FDG PET/CT for the diagnosis and management of cancer patients with increasing levels of tumor markers as the sole indicator of potential recurrence after initial successful treatment. METHODS: Thirty-six cancer patients with increasing levels of tumor markers during follow-up and negative CT underwent (18)F-FDG PET/CT, which showed 111 sites of increased tracer uptake. PET/CT was compared with PET results on a site-based analysis for characterization of (18)F-FDG foci and on a patient-based analysis for diagnosis of recurrence. The clinical impact of PET/CT on further patient management was evaluated. RESULTS: Thirty patients (83%) had recurrence in 85 malignant sites (77%). For the site-based analysis, PET had a sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of 96%, 50%, 85%, 85%, and 82%, respectively, as compared with the performance indices of PET/CT of 100%, 89%, 97%, 97%, and 100%, respectively. There was a statistically significant difference between the specificity (P < 0.05) and accuracy (P < 0.001) of PET and PET/CT for precise characterization of suspected lesions. For the patient-based analysis, PET had a sensitivity, specificity, and accuracy of 93%, 50%, and 86%, respectively, as compared with PET/CT with values of 93%, 67%, and 89%, respectively (P = not significant). PET/CT was the single modality that directed further management and treatment planning in 12 patients (33%). CONCLUSION: The results of this study indicate that PET/CT may improve the accuracy of occult cancer detection and further lead to management changes in patients with increasing levels of tumor markers as the sole suspicion of recurrent malignancy. 相似文献
53.
54.
Wilson's disease in children: 37-year experience and revised King's score for liver transplantation.
Anil Dhawan Rachel M Taylor Paul Cheeseman Pamela De Silva Leah Katsiyiannakis Giorgina Mieli-Vergani 《Liver transplantation》2005,11(4):441-448
Wilson's disease (WD) is a rare liver-based disorder of copper metabolism. Prognostic criteria described by our group in 1986 to predict death without transplantation have not been universally validated. The clinical features of 88 children were reviewed, retrospectively in 74 and prospectively in 14. Data from the retrospectively recruited patients that died or survived on long-term chelation were used to evaluate the validity of our old scoring system and to devise a new prognostic index, then assessed in the 14 prospectively recruited patients. Using the old scoring system, 5 children scoring > or = 7, the cutoff value for death without transplantation, survived, whereas 4 scoring < or = 7 died (sensitivity 87% and specificity 90%). A new index based on serum bilirubin, international normalized ratio, aspartate aminotransferase (AST), and white cell count (WCC) at presentation identified a cutoff score of 11 for death and proved to be 93% sensitive and 98% specific, with a positive predictive value of 88%. When the new index was evaluated prospectively in 14 patients, it predicted the need for transplantation in only the 4 who required it, although 1 child with a score of 11 survived on medical treatment. In conclusion, the new Wilson Index is more sensitive and specific in predicting mortality without transplantation than the old scoring system, but needs to be validated in a larger number of patients. 相似文献
55.
56.
Douglas L Riegert-Johnson Charles J Bruce Victor M Montori Rachel J Cook Peter C Spittell 《Journal of the American Society of Echocardiography》2005,18(5):394-397
Our objective was to test the hypothesis that internal medicine residents can be trained to screen for abdominal aortic aneurysm (AAA) using personal ultrasound imagers. We trained 5 randomly chosen internal medicine residents to image the abdominal aorta for patients with risk factors for AAAs using personal ultrasound imagers. Residents were trained in 3 or 4 one-on-one sessions with an instructor. To be eligible, patients had to be older than 65 years and have hypertension. After training, each of the 5 residents studied 3 patients independently. In 12 of the residents' 15 unsupervised studies, their abdominal aorta measurements were within 5 mm of the instructor's measurements with standard echocardiography (mean difference 3 mm, range 0-6 mm). Residents detected 3 previously unknown AAAs measuring 5.2, 4.2, and 3.9 cm in diameter. We conclude residents can be trained to image the abdominal aorta with personal ultrasound imagers and to identify AAAs in patients at risk. 相似文献
57.
·病例简介:患者,男,22岁。因鼻部(见图1)、左侧肩部(见图2)、右侧背部及左侧大腿部皮疹就诊。既往身体健康,近期有到加利福尼亚中央谷旅游史,否认异地长期居住史,近期无服药史。患者无发热,无夜间盗汗,无寒战。既往诊断为耐甲氧西林金黄色葡萄球菌(MRSA)感染,接受甲氧苄氨嘧啶 相似文献
58.
Christian Otte Maryann Lenoci Thomas Metzler Rachel Yehuda Charles R Marmar Thomas C Neylan 《Neuropsychopharmacology》2007,61(8):952-956
BACKGROUND: Metyrapone blocks cortisol synthesis which results in removal of negative feedback, a stimulation of hypothalamic corticotropin releasing factor (CRF) and a reduction in delta sleep. We previously reported a diminished delta sleep and hypothalamic-pituitary-adrenal (HPA) response to metyrapone in men with post-traumatic stress disorder (PTSD). In this study, we aimed to extend these findings to women. METHODS: Three nights of polysomnography were obtained in 17 women with PTSD and 16 controls. On day 3, metyrapone was administered throughout the day up until bedtime. Plasma adrenocorticotropic hormone (ACTH), cortisol, and 11-deoxycortisol were obtained the morning following sleep recordings the day before and after metyrapone administration. RESULTS: There were no significant between-group differences in hormone concentration and delta sleep at baseline. Relative to controls, women with PTSD had decreased ACTH and delta sleep responses to metyrapone. Decline in delta sleep was associated with the magnitude of increase in ACTH across groups. CONCLUSIONS: Similar to our previous findings in men, the ACTH and sleep electroencephalogram response to metyrapone is attenuated in women with PTSD. These results are consistent with a model of downregulation of CRF receptors in an environment of chronically increased CRF activity or with enhanced negative feedback regulation in PTSD. 相似文献
59.
Botulinum Toxin A in the Treatment of Chromhidrosis 总被引:1,自引:0,他引:1
Wu Jessie M. Mamelak Adam J. MD † Nussbaum Rachel MD † McElgunn Patrick S. J. MD MBA † 《Dermatologic surgery》2005,31(8):963-965
Background. Chromhidrosis is an uncommon disorder characterized by secretion of colored sweat by apocrine glands, typically localized to the face or axilla. The current treatments available for chromhidrosis are time consuming and frequently ineffective.
Objective. Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
Methods. We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
Results. BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
Conclusion. This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis. 相似文献
Objective. Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
Methods. We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
Results. BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
Conclusion. This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis. 相似文献